# FDA Inspection 1260551 - JQC (Huayin) Pharmaceutical Co., Ltd. - January 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/jqc-huayin-pharmaceutical-co-ltd/4ece8965-bde4-4855-bf0b-2e523164ebf5
Source feed: FDA_Inspections

> FDA Inspection 1260551 for JQC (Huayin) Pharmaceutical Co., Ltd. on January 17, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260551
- Company Name: JQC (Huayin) Pharmaceutical Co., Ltd.
- Inspection Date: 2025-01-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260551 - 2025-01-17](https://www.keypedia.com/records/fda_inspections/jqc-huayin-pharmaceutical-co-ltd/5c75c944-3363-4a2c-b6df-8de346585e49)
- [FDA Inspection 997257 - 2016-12-09](https://www.keypedia.com/records/fda_inspections/jqc-huayin-pharmaceutical-co-ltd/614fd715-f89f-48ab-b642-5a586ec335f3)
- [FDA Inspection 818181 - 2013-01-24](https://www.keypedia.com/records/fda_inspections/jqc-huayin-pharmaceutical-co-ltd/6e5a2571-f949-4ca5-8407-3e46e2bde4ee)

Company: https://www.keypedia.com/companies/jqc-huayin-pharmaceutical-co-ltd/fc857ff5-2f1d-4427-8752-573874b3b6c9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c